Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 485213, 10 pages
http://dx.doi.org/10.1155/2013/485213
Research Article

Effects of Muscarinic Acetylcholine 3 Receptor208-227 Peptide Immunization on Autoimmune Response in Nonobese Diabetic Mice

Key Autoimmunity Lab of Inner Mongolia, Institution of Immunology and Rheumatism, Baotou Medical College, No. 41 Lin yin Road, Baotou 014010, China

Received 4 June 2013; Revised 18 November 2013; Accepted 25 November 2013

Academic Editor: Yoshihiko Hoshino

Copyright © 2013 Lin Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. A. Waterman, T. P. Gordon, and M. Rischmueller, “Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren’s syndrome,” Arthritis and Rheumatism, vol. 43, pp. 1647–1654, 2000. View at Google Scholar
  2. L. Dawson, A. Tobin, P. Smith, and T. Gordon, “Antimuscarinic antibodies in Sjögren’s syndrome,” Arthritis and Rheumatism, vol. 52, pp. 2984–2995, 2005. View at Google Scholar
  3. M. Iizuka, E. Wakamatsu, H. Tsuboi et al., “Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis,” Journal of Autoimmunity, vol. 35, no. 4, pp. 383–389, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. C. P. Robinson, J. Brayer, S. Yamachika et al., “Transfer of human serum IgG to nonobese diabetic Igμnull mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 13, pp. 7538–7543, 1998. View at Google Scholar · View at Scopus
  5. J. C. Goin, E. Borda, C. P. Leiros, R. Storino, and L. Sterin-Borda, “Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications,” Journal of the Autonomic Nervous System, vol. 47, no. 1-2, pp. 45–52, 1994. View at Google Scholar · View at Scopus
  6. P. Eftekhari, L. Salle, F. Lezoualc'h et al., “Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4, serotoninergic receptor could explain neonatallupus congenital heart block,” European Journal of Immunology, vol. 30, pp. 2782–2790, 2000. View at Google Scholar
  7. Y. Magnusson, S. Marullo, S. Hoyer et al., “Mapping of a functional autoimmune epitope on the β1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy,” Journal of Clinical Investigation, vol. 86, no. 5, pp. 1658–1663, 1990. View at Google Scholar · View at Scopus
  8. K. Nguyen, J. Broyer, S. Cha, S. Diggs, U. Yasunari, and G. Hilal, “Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice,” Arthritis and Rheumatism, vol. 43, pp. 2297–2306, 2000. View at Google Scholar
  9. L. Kovács, I. Marczinovits, A. György et al., “Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjögren’s syndrome,” Rheumatology, vol. 44, pp. 1021–1025, 2005. View at Google Scholar
  10. I. Marczinovits, L. Kovács, A. György et al., “A peptide of human muscarinic acetylcholine receptor 3 is antigenic in primary Sjögren’s syndrome,” Journal of Autoimmunity, vol. 24, pp. 47–54, 2005. View at Google Scholar
  11. D. Cavill, S. A. Waterman, and T. P. Gordon, “Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome,” Scandinavian Journal of Immunology, vol. 59, no. 3, pp. 261–266, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. N.-Y. Koo, J. Li, S.-M. Hwang et al., “Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjögren's syndrome patients,” Rheumatology, vol. 47, no. 6, pp. 828–833, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Naito, I. Matsumoto, E. Wakamatsu et al., “Altered peptide ligands regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjögren's syndrome,” Annals of the Rheumatic Diseases, vol. 65, no. 2, pp. 269–271, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J. S. Greenspan, T. E. Daniels, N. Talal, and R. A. Sylvester, “The histopathology of Sjogren's syndrome in labial salivary gland biopsies,” Oral Surgery Oral Medicine and Oral Pathology, vol. 37, no. 2, pp. 217–229, 1974. View at Google Scholar · View at Scopus
  15. C. S. de Paiva, C. S. Hwang, J. D. I. Pitcher et al., “Age-related T-cell cytokine profile parallels corneal disease severity in Sjögren's syndrome-like keratoconjunctivitis sicca in CD25KO mice,” Rheumatology, vol. 49, no. 2, Article ID kep357, pp. 246–258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger, “TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells,” Immunity, vol. 24, no. 2, pp. 179–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. P. R. Mangan, L. E. Harrington, D. B. O'Quinn et al., “Transforming growth factor-β induces development of the T H17 lineage,” Nature, vol. 441, no. 7090, pp. 231–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. I. I. Ivanov, B. S. McKenzie, L. Zhou et al., “The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells,” Cell, vol. 126, no. 6, pp. 1121–1133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Elias, T. Reshef, O. S. Birk, R. van der Zee, M. D. Walker, and I. R. Cohen, “Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 8, pp. 3088–3091, 1991. View at Google Scholar · View at Scopus
  21. J. He, J. Zhao, and Z. Li, “Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity,” Arthritis Research and Therapy, vol. 10, no. 2, article R44, 2008. View at Google Scholar
  22. C. Q. Nguyen, H. Yin, B. H. Lee, W. C. Carcamo, J. A. Chiorini, and A. B. Peck, “Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer,” Arthritis Research and Therapy, vol. 12, no. 6, article R220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Bettelli, T. Korn, M. Oukka, and V. K. Kuchroo, “Induction and effector functions of TH17 cells,” Nature, vol. 453, no. 7198, pp. 1051–1057, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Q. Nguyen, M. H. Hu, Y. Li, C. Stewart, and A. B. Peck, “Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice,” Arthritis and Rheumatism, vol. 58, no. 3, pp. 734–743, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Sakai, Y. Sugawara, T. Kuroishi, T. Sasano, and S. Sugawara, “Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18,” Journal of Immunology, vol. 181, no. 4, pp. 2898–2906, 2008. View at Google Scholar · View at Scopus
  26. C. S. de Paiva, S. Chotikavanich, S. B. Pangelinan et al., “IL-17 disrupts corneal barrier following desiccating stress,” Mucosal Immunology, vol. 2, no. 3, pp. 243–253, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Konno, K. Takada, J. Saegusa, and M. Takiguchi, “Presence of B7-2+ dendritic cells and expression of Th1 cytokines in the early development of sialodacryoadenitis in the IQI/Jic mouse model of primary Sjögren's syndrome,” Autoimmunity, vol. 36, no. 4, pp. 247–254, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. J. B. Brayer, S. Cha, H. Nagashima et al., “IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren's syndrome,” Scandinavian Journal of Immunology, vol. 54, no. 1-2, pp. 133–140, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Bertorello, M. P. Cordone, P. Contini et al., “Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients: correlation with disease activity,” Clinical and Experimental Medicine, vol. 4, no. 3, pp. 148–151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. J.-M. Anaya, P. A. Correa, M. Herrera, J. Eskdale, and G. Gallagher, “Interleukin 10 (IL-10) influences autoimmune response in primary Sjögren's syndrome and is linked to IL-10 gene polymorphism,” Journal of Rheumatology, vol. 29, no. 9, pp. 1874–1876, 2002. View at Google Scholar · View at Scopus
  31. M. V. Jonsson, N. Delaleu, K. A. Brokstad, E. Berggreen, and K. Skarstein, “Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland,” Arthritis and Rheumatism, vol. 54, no. 7, pp. 2300–2305, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Tsuboi, I. Matsumoto, E. Wakamatsu et al., “New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome,” Clinical and Experimental Immunology, vol. 162, no. 1, pp. 53–61, 2010. View at Publisher · View at Google Scholar · View at Scopus